Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants.

Abstract:

OBJECTIVES:There has been recent renewed interest in historical antibiotics because of the increased antibiotic-resistant bacterial strains. Latamoxef, a semi-synthetic oxacephem antibiotic developed in 1980s, has recently been brought back into use for treatment of infections in newborns; however, it is still used off-label in neonatal clinical practice due to the lack of an evidence-based dosing regimen. This study was performed to evaluate the pharmacokinetics of latamoxef in neonates and young infants, and to provide an evidence-based dosing regimen for newborns based on developmental pharmacokinetics-pharmacodynamics (PK-PD). METHODS:Opportunistic blood samples from newborns treated with latamoxef were collected to determine the latamoxef concentration by high-performance liquid chromatography with UV detection. Population PK-PD analysis was conducted using NONMEM and R software. A total of 165 plasma samples from 128 newborns (postmenstrual age range 28.4-46.1 weeks) were available for analysis. RESULTS:A two-compartment model with first-order elimination showed the best fit with the data. Current body weight, birth weight, and postnatal age were identified as significant covariates influencing latamoxef clearance. Simulation indicated that the current dosing regimen (30 mg/kg q12h) is adequate with an MIC of 1 mg/L. For an MIC of 4 mg/L, 30 mg/kg q8h was required to achieve a target rate of 70% of patients having a free antimicrobial drug concentration exceeding the MIC during 70% of the dosing interval. CONCLUSIONS:Based on the developmental PK-PD analysis of latamoxef, a rational dosing regimen of 30 mg/kg q12h or q8h was required in newborns, depending on the pathogen.

authors

Qi H,Kou C,Qi YJ,Tang BH,Wu YE,Jin F,Luo XJ,Shen YH,Guo YJ,Qi X,Wang YC,Dong Q,Chen XK,Shi HY,Zheng Y,Zhao W,Shen AD

doi

10.1016/j.ijantimicag.2018.11.017

subject

Has Abstract

pub_date

2019-03-01 00:00:00

pages

347-351

issue

3

eissn

0924-8579

issn

1872-7913

pii

S0924-8579(18)30342-X

journal_volume

53

pub_type

杂志文章
  • In vitro and intracellular activities of fosfomycin against clinical strains of Listeria monocytogenes.

    abstract::This study was designed to evaluate the potential role of fosfomycin as a therapeutic agent in human listeriosis. The in vitro activity of fosfomycin against 154 Listeria monocytogenes clinical isolates under conditions that mimic the induction of prfA expression was determined and was correlated with fosfomycin intra...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2013.10.018

    authors: Lepe JA,Torres MJ,Smani Y,Parra-Millán R,Pachón J,Vazquez-Barba I,Aznar J

    更新日期:2014-02-01 00:00:00

  • Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.

    abstract::Seventy-three Salmonella isolates classified as ciprofloxacin susceptible when using the criteria of the National Committee for Clinical Laboratory Standards were studied for nalidixic acid (NA) resistance. The aim of the study was to determine the predictive value of nalidixic acid resistance in screening for decreas...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2003.09.014

    authors: Albayrak F,Cokca F,Erdem B,Aysev AD

    更新日期:2004-04-01 00:00:00

  • Effects of sub-minimum inhibitory concentrations of antimicrobial agents on Streptococcus mutans biofilm formation.

    abstract::Many studies have demonstrated that sub-minimum inhibitory concentrations (sub-MICs) of antimicrobial agents can inhibit bacterial biofilm formation. However, the mechanisms by which antimicrobial agents at sub-MICs inhibit biofilm formation remain unclear. At present, most studies are focused on Gram-negative bacteri...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2012.01.009

    authors: Dong L,Tong Z,Linghu D,Lin Y,Tao R,Liu J,Tian Y,Ni L

    更新日期:2012-05-01 00:00:00

  • Effect of administration of diethylcarbamazine on experimental bacterial and fungal infections in mice.

    abstract::Other researchers have found that diethylcarbamazine (DEC) is effective treatment for filariasis despite a lack of demonstrated in vitro antifilarial activity. The results of our previous investigations using feline and murine leukemia virus models encouraged us to investigate the use of DEC with other infections. In ...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/0924-8579(92)90037-r

    authors: Kitchen LW,Ross JA,Hernandez JE,Zarraga AL,Mather FJ

    更新日期:1992-09-01 00:00:00

  • Characterisation of the metallo-beta-lactamase VIM-6 and its genetic support.

    abstract::The purpose of this study was to characterise the metallo-beta-lactamase VIM-6 and the genetic environment of the bla(VIM-6) gene. The bla(VIM-6) gene was cloned into an Escherichia coli expression system and the purified VIM-6 enzyme was obtained. VIM-6 has an isoelectric point of 4.9 and a molecular weight of 28.368...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2008.05.017

    authors: Koh TH,Yamaguchi K,Ishii Y

    更新日期:2008-11-01 00:00:00

  • In vitro activity of linezolid against Gram-positive uropathogens of hospitalized patients with complicated urinary tract infections.

    abstract::The antimicrobial activity of linezolid, a recently developed antibiotic agent active against Gram-positive bacteria, was tested against pathogens from three different collections. (1) Uropathogens from hospitalized urological patients (1990/1991) with complicated and/or hospital-acquired UTIs; Urologic Clinic, Hospit...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/s0924-8579(01)00374-0

    authors: Onda H,Wagenlehner FM,Lehn N,Naber KG

    更新日期:2001-09-01 00:00:00

  • Why new antibiotics are not obviously useful now.

    abstract::For several years, the threat of antibiotic resistance and its health cost has dramatically risen and various alarming figures have been proposed to illustrate the mortality due to antibiotic resistance. However, predictions concerning different living beings are doomed to failure, as theorised in Alice's 'living croq...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijantimicag.2016.11.015

    authors: Dubourg G,Abat C,Raoult D

    更新日期:2017-05-01 00:00:00

  • Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance.

    abstract::The objective of this study was to comprehensively identify the target genes regulated by the two-component regulatory system VraSR in Staphylococcus aureus and to clarify the role of VraSR in low-level vancomycin resistance. Expression of vraS was determined by real-time quantitative reverse transcriptase PCR (qRT-PC...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2016.02.003

    authors: Chen H,Xiong Z,Liu K,Li S,Wang R,Wang X,Zhang Y,Wang H

    更新日期:2016-05-01 00:00:00

  • Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.

    abstract::Extended-spectrum β-lactamase-producing Escherichia coli (ESBL-Ec) is a frequent cause of acute pyelonephritis (APN), requiring carbapenem therapy. However, alternatives to carbapenems are needed due to the emergence of carbapenemase-producing micro-organisms. The purpose of this study was to compare the clinical effi...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2016.12.017

    authors: Yoon YK,Kim JH,Sohn JW,Yang KS,Kim MJ

    更新日期:2017-04-01 00:00:00

  • In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus.

    abstract::The in vitro activities of sitafloxacin and seven other fluoroquinolones a (ciprofloxacin, tosufloxacin, sparfloxacin, levofloxacin, T-3811ME, moxifloxacin and trovafloxacin) were examined by the microdilution method against 79 clinically isolated 'Streptococcus milleri' group (SMG) microorganisms. No statistically si...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2005.10.006

    authors: Yamamoto N,Fujita J,Shinzato T,Higa F,Tateyama M,Tohyama M,Nakasone I,Yamane N

    更新日期:2006-02-01 00:00:00

  • The effect of food on plasma and tissue concentrations of linezolid after multiple doses.

    abstract::In the present pilot study we investigated the effect of food ingestion on target site pharmacokinetics of linezolid, the first clinically approved oxazolidinone. For this purpose we determined free concentrations of linezolid at steady state in the interstitial space fluid of skeletal muscle and subcutaneous adipose ...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2005.09.017

    authors: Islinger F,Dehghanyar P,Sauermann R,Bürger C,Kloft C,Müller M,Joukhadar C

    更新日期:2006-02-01 00:00:00

  • Susceptibility of lactic acid bacteria, bifidobacteria and other bacteria of intestinal origin to chemotherapeutic agents.

    abstract::Chemotherapy is a cornerstone of cancer treatment but it can have serious side effects, such as intestinal mucositis. This work reports the susceptibility/resistance profiles of 34 species of lactic acid bacteria (LAB), bifidobacteria and other intestinal bacteria from different collections to various chemotherapeutic...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2016.07.011

    authors: Flórez AB,Sierra M,Ruas-Madiedo P,Mayo B

    更新日期:2016-11-01 00:00:00

  • Prevalence of β-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants.

    abstract::To characterise the prevalence of β-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance (PMQR) determinants in China, 59 non-duplicate K. pneumoniae isolates harbouring at least one PMQR gene were screened for common β-lactamases and 16...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2010.12.018

    authors: Luo Y,Yang J,Zhang Y,Ye L,Wang L,Guo L

    更新日期:2011-04-01 00:00:00

  • Strategies for the treatment and prevention of cytomegalovirus infections.

    abstract::Currently, only two drugs, i.e. ganciclovir, (DHPG, cytovene)_and foscarent (PFA, Foscavir), are licenced for the treatment of severe CMV infections. Both compounds may have serious side effects and can lead to the emergence of drug-resistant virus strains. Recent pertain to the efficacy of prophylactic or pre-emptive...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/0924-8579(93)90012-t

    authors: Neyts J,De Clercq E

    更新日期:1993-01-01 00:00:00

  • Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK.

    abstract::The novel ketolide telithromycin (formerly HMR-3647) was tested against a collection of pneumococci of varying sensitivity to erythromycin and clindamycin, isolated in geographically diverse UK hospitals. Telithromycin was highly active against erythromycin-susceptible pneumococci, the MIC(90) being 0.015 mg/l. Erythr...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/s0924-8579(01)00346-6

    authors: Johnson AP,Henwood CJ,Tysall L,Warner M

    更新日期:2001-07-01 00:00:00

  • Drug resistance characteristics of Mycobacterium tuberculosis isolates to four first-line antituberculous drugs from tuberculosis patients with AIDS in Beijing, China.

    abstract::The objective of this study was to investigate the drug resistance characteristics of Mycobacterium tuberculosis isolates to four first-line antituberculous drugs (ATDs) from tuberculosis (TB) patients with AIDS in Beijing, China. All M. tuberculosis strains were isolated from specimens from TB patients with AIDS hosp...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2014.09.013

    authors: Gao GJ,Lian L,Sun Y,Wei J,Xiao J,Wang X,Zhang L,Zhao X,Yang D,Zhao HX,Zhao H,Wang HZ,Wan KL,Li XW

    更新日期:2015-02-01 00:00:00

  • Contribution of β-lactamase and efflux pump overproduction to tazobactam-piperacillin resistance in clinical isolates of Escherichia coli.

    abstract:INTRODUCTION:Tazobactam-piperacillin (TZP) is a mixture of a broad-spectrum penicillin and an irreversible β-lactamase inhibitor. TZP is effective against Gram-negative bacteria that produce extended-spectrum β-lactamases, and it is used as a first-line or second-line drug to treat serious infections. METHODS:This stu...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2020.105919

    authors: Suzuki Y,Sato T,Fukushima Y,Nakajima C,Suzuki Y,Takahashi S,Yokota SI

    更新日期:2020-04-01 00:00:00

  • Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003).

    abstract::Isolates of Streptococcus pneumoniae collected over the first 4 years of the PROTEKT study were tested for susceptibility to penicillin, azithromycin and telithromycin. A total of 20,750 isolates were collected from 39 countries. Penicillin non-susceptibility rates were stable over the study period; overall, 21.8% of ...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.ijantimicag.2005.04.022

    authors: Schito GC,Felmingham D

    更新日期:2005-12-01 00:00:00

  • Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.

    abstract::Invasive pulmonary aspergillosis (IPA) is an increasingly recognised problem in critically ill patients. Little is known about how intensivists react to an Aspergillus-positive respiratory sample or the efficacy of antifungal therapy (AFT). This study aimed to identify drivers of AFT prescription and diagnostic workup...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2017.05.017

    authors: Paiva JA,Mergulhão P,Gomes A,Taccone FS,Van den Abeele AM,Bulpa P,Misset B,Meersseman W,Dimopoulos G,Rello J,Vogelaers D,Blot S

    更新日期:2017-10-01 00:00:00

  • Characterisation of extended-spectrum β-lactamase/plasmid AmpC-β-lactamase-producing Escherichia coli isolates from long-term recurrent bloodstream infections.

    abstract::The aim of this study was to investigate recurrent infections in individual patients caused by extended-spectrum β-lactamase and plasmid AmpC β-lactamase-producing Escherichia coli (ESBL/pAmpC-Ec) isolates with >12-month interval. The Danish national collection of ESBL/pAmpC-Ec isolates collected from January 2014 thr...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2020.106041

    authors: Roer L,Hansen F,Hasman H,Hammerum AM,Cavaco LM

    更新日期:2020-07-01 00:00:00

  • Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis.

    abstract::Antimicrobial peptides (AMPs) are essential host defence molecules found in a wide variety of species and are promising antibacterial therapeutic candidates. Focusing on the human cathelicidin peptide LL-37, the aim of the present study was to explore the mechanisms of action and antimicrobial activities of a library ...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2010.06.031

    authors: Kanthawong S,Bolscher JG,Veerman EC,van Marle J,Nazmi K,Wongratanacheewin S,Taweechaisupapong S

    更新日期:2010-11-01 00:00:00

  • Antiviral therapy of herpes simplex.

    abstract::Herpes simplex virus (HSV) infections in immunocompromised patients are more severe and invasive than in non-immunocompromised patients. They are characterised by prolonged viral shedding and a tendency to heal more slowly. In addition, resistant viruses are exclusively isolated in immunocompromised patients, requirin...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,评审

    doi:10.1016/s0924-8579(00)00233-8

    authors: Snoeck R

    更新日期:2000-10-01 00:00:00

  • In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.

    abstract::Macrolides, especially clarithromycin (CLA), remain the cornerstone of therapy for Mycobacterium abscessus complex infections. The purpose of this study was to gather results from in vitro drug susceptibility testing of M. abscessus and Mycobacterium massiliense for the combination of CLA with various other agents, in...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2016.12.003

    authors: Zhang Z,Lu J,Liu M,Wang Y,Zhao Y,Pang Y

    更新日期:2017-03-01 00:00:00

  • In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.

    abstract::The resistance rates of ampicillin/sulbactam 2:1 against imipenem-susceptible and -resistant Acinetobacter baumannii were 23.5 and 30%, respectively. Ceftazidime/sulbactam combination showed significant reduction of resistant rates against Enterobacter cloacae, A. baumannii, ESBL Klebsiella pneumoniae. MIC90 of cefope...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2003.10.008

    authors: Wang FD,Lin ML,Lee WS,Liu CY

    更新日期:2004-06-01 00:00:00

  • Serum concentrations and pharmacokinetics of moxifloxacin in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

    abstract::Although cephalosporins are recommended as primary agents, moxifloxacin may be a suitable second-line antibiotic in cardiac surgery, especially if additional Gram-negative coverage is warranted. Cardiopulmonary bypass (CPB) may alter the pharmacokinetics of drugs in numerous ways. Since no such data exist, the aim of ...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2013.01.017

    authors: Wiesner G,Martin K,Gertler R,Braun SL,Tassani P,Lange R,Gruber M

    更新日期:2013-05-01 00:00:00

  • Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.

    abstract::The mutant prevention concentration (MPC) was determined by population analysis using six fluoroquinolone-susceptible isolates of Pseudomonas aeruginosa applied to fluoroquinolone-containing agar plates. The MPCs were 3 mg/L and 9.5 mg/L for ciprofloxacin and levofloxacin, respectively. At high concentrations of eithe...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2005.10.005

    authors: Hansen GT,Zhao X,Drlica K,Blondeau JM

    更新日期:2006-02-01 00:00:00

  • Five-year trends for ventilator-associated pneumonia: Correlation between microbiological findings and antimicrobial drug consumption.

    abstract::The epidemiology of multidrug-resistant bacteria (MDRB) has changed significantly in European healthcare settings, with a decrease in frequency of meticillin-resistant Staphylococcus aureus and an increase in extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. Little is known about the effects of these ...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2015.07.010

    authors: Fihman V,Messika J,Hajage D,Tournier V,Gaudry S,Magdoud F,Barnaud G,Billard-Pomares T,Branger C,Dreyfuss D,Ricard JD

    更新日期:2015-11-01 00:00:00

  • Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.

    abstract::The aim of this study was to compare the antibacterial activity of teicoplanin and vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) meningitis using a rabbit meningitis model. The MRSA strain ATCC 43300 was used to infect the rabbits. The vancomycin group received 20 mg/kg vancomycin e...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2005.08.011

    authors: Sipahi OR,Arda B,Yurtseven T,Sipahi H,Ozgiray E,Suntur BM,Ulusoy S

    更新日期:2005-11-01 00:00:00

  • Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils.

    abstract::It has been previously demonstrated that some antimicrobial agents enhance activities of human polymorphonuclear neutrophils (PMNs). The effect on the release of cytokines in an inflammatory context from PMNs by these antibiotics was evaluated. We studied the effect of the release of some cytokines by human PMNs RT-PC...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2003.07.006

    authors: Reato G,Cuffini AM,Tullio V,Mandras N,Roana J,Banche G,Foa R,Carlone NA

    更新日期:2004-02-01 00:00:00

  • Subinhibitory concentrations of beta-lactams and other cell-wall antibiotics inhibit listeriolysin production by Listeria monocytogenes.

    abstract::In the present study we tested the ability of beta-lactam antibiotics and other cell-wall antibiotics to inhibit the production of listeriolysin which is the main virulence factor of L. monocytogenes. The amount of listeriolysin produced was measured in the supernatants with a sensitive hemolysin assay and as beta-gal...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/0924-8579(96)00014-3

    authors: Nichterlein T,Domann E,Kretschmar M,Bauer M,Hlawatsch A,Hof H,Chakraborty T

    更新日期:1996-05-01 00:00:00